12 June 2014
R 150 million boost to eradicate TB in South Africa
The SA Medical Research Council (SAMRC) is reaffirming and strengthening its role as the custodian of health research aimed at building a healthy nation through research and innovation.
June will see SHIP, a new innovative product development programme within the SAMRC, activate funding to the tune of R 150 million for projects aimed at turning the tide of TB in South Africa. The three key programmes, funded over a period of three years, are in the areas: Drug discovery and translational medicine applications; Vaccine development and Diagnostics.
“In order to curb TB in South Africa, we have to think outside the box, we have to fund innovations that will directly translate in adequately diagnosing and curing TB, “says President of the SA Medical Research Council Professor Glenda Gray. “Finding a TB vaccine that will prevent TB transmission in our communities will be paramount for the SAMRC,” she adds.
“The Strategic Health Innovation Partnerships unit is strongly committed to the fight against TB”, says Dr Richard Gordon, Director of SHIP. “We are delighted to be supporting South African scientists in leading many of these activities.”
The projects, announced in January 2014 in Cape Town, are led by world class principal investigators from Universities across the country and are in response to the pressing need to develop innovative interventions and preventative strategies to address the TB pandemic.
A handful of Principal Investigators dedicated to these SHIP projects will be presenting at the 4th TB Conference held at the Durban ICC from 11-13 June 2014.
NOTES TO THE MEDIA PRACTITIONER:
Read more information on the SHIP 2014 Projects
Head of Corporate Communications
South African Medical Research Council (SAMRC)
Tel: +27 21 938 0697; Mobile: +27 71 866 9887